Analystreport

TapImmune Inc. (NASDAQ: MRKR) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Marker Therapeutics, Inc.  (MRKR) 
Last marker therapeutics, inc. earnings: 11/12 04:01 pm Check Earnings Report